Global Noninvasive Prenatal Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 288867
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Noninvasive Prenatal Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Noninvasive Prenatal Diagnostics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Noninvasive Prenatal Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Services segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Noninvasive Prenatal Diagnostics include Natera, Illumina, BGI Diagnosis, Ariosa Diagnostics, and Quest Diagnostics, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Noninvasive Prenatal Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Services

Instrument

Market segment by Application, can be divided into

Hospital

Personal

Other

Market segment by players, this report covers

Natera

Illumina

BGI Diagnosis

Ariosa Diagnostics

Quest Diagnostics

Premaitha Health

NIPD Genetics

Labcorp

Ravgen

LifeCodexx

TrovaGene

Quest Diagnostics

Berry Genomics

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Noninvasive Prenatal Diagnostics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Noninvasive Prenatal Diagnostics, with revenue, gross margin and global market share of Noninvasive Prenatal Diagnostics from 2019 to 2022.

Chapter 3, the Noninvasive Prenatal Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Noninvasive Prenatal Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Noninvasive Prenatal Diagnostics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Noninvasive Prenatal Diagnostics

1.2 Classification of Noninvasive Prenatal Diagnostics by Type

1.2.1 Overview: Global Noninvasive Prenatal Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type in 2021

1.2.3 Services

1.2.4 Instrument

1.3 Global Noninvasive Prenatal Diagnostics Market by Application

1.3.1 Overview: Global Noninvasive Prenatal Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospital

1.3.3 Personal

1.3.4 Other

1.4 Global Noninvasive Prenatal Diagnostics Market Size & Forecast

1.5 Global Noninvasive Prenatal Diagnostics Market Size and Forecast by Region

1.5.1 Global Noninvasive Prenatal Diagnostics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Noninvasive Prenatal Diagnostics Market Size by Region, (2017-2022)

1.5.3 North America Noninvasive Prenatal Diagnostics Market Size and Prospect (2017-2028)

1.5.4 Europe Noninvasive Prenatal Diagnostics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size and Prospect (2017-2028)

1.5.6 South America Noninvasive Prenatal Diagnostics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Noninvasive Prenatal Diagnostics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Noninvasive Prenatal Diagnostics Market Drivers

1.6.2 Noninvasive Prenatal Diagnostics Market Restraints

1.6.3 Noninvasive Prenatal Diagnostics Trends Analysis

2 Company Profiles

2.1 Natera

2.1.1 Natera Details

2.1.2 Natera Major Business

2.1.3 Natera Noninvasive Prenatal Diagnostics Product and Solutions

2.1.4 Natera Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Natera Recent Developments and Future Plans

2.2 Illumina

2.2.1 Illumina Details

2.2.2 Illumina Major Business

2.2.3 Illumina Noninvasive Prenatal Diagnostics Product and Solutions

2.2.4 Illumina Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Illumina Recent Developments and Future Plans

2.3 BGI Diagnosis

2.3.1 BGI Diagnosis Details

2.3.2 BGI Diagnosis Major Business

2.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Product and Solutions

2.3.4 BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 BGI Diagnosis Recent Developments and Future Plans

2.4 Ariosa Diagnostics

2.4.1 Ariosa Diagnostics Details

2.4.2 Ariosa Diagnostics Major Business

2.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions

2.4.4 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Ariosa Diagnostics Recent Developments and Future Plans

2.5 Quest Diagnostics

2.5.1 Quest Diagnostics Details

2.5.2 Quest Diagnostics Major Business

2.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions

2.5.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Quest Diagnostics Recent Developments and Future Plans

2.6 Premaitha Health

2.6.1 Premaitha Health Details

2.6.2 Premaitha Health Major Business

2.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Product and Solutions

2.6.4 Premaitha Health Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Premaitha Health Recent Developments and Future Plans

2.7 NIPD Genetics

2.7.1 NIPD Genetics Details

2.7.2 NIPD Genetics Major Business

2.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Product and Solutions

2.7.4 NIPD Genetics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 NIPD Genetics Recent Developments and Future Plans

2.8 Labcorp

2.8.1 Labcorp Details

2.8.2 Labcorp Major Business

2.8.3 Labcorp Noninvasive Prenatal Diagnostics Product and Solutions

2.8.4 Labcorp Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Labcorp Recent Developments and Future Plans

2.9 Ravgen

2.9.1 Ravgen Details

2.9.2 Ravgen Major Business

2.9.3 Ravgen Noninvasive Prenatal Diagnostics Product and Solutions

2.9.4 Ravgen Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Ravgen Recent Developments and Future Plans

2.10 LifeCodexx

2.10.1 LifeCodexx Details

2.10.2 LifeCodexx Major Business

2.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Product and Solutions

2.10.4 LifeCodexx Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 LifeCodexx Recent Developments and Future Plans

2.11 TrovaGene

2.11.1 TrovaGene Details

2.11.2 TrovaGene Major Business

2.11.3 TrovaGene Noninvasive Prenatal Diagnostics Product and Solutions

2.11.4 TrovaGene Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 TrovaGene Recent Developments and Future Plans

2.12 Quest Diagnostics

2.12.1 Quest Diagnostics Details

2.12.2 Quest Diagnostics Major Business

2.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions

2.12.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Quest Diagnostics Recent Developments and Future Plans

2.13 Berry Genomics

2.13.1 Berry Genomics Details

2.13.2 Berry Genomics Major Business

2.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Product and Solutions

2.13.4 Berry Genomics Noninvasive Prenatal Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Berry Genomics Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Noninvasive Prenatal Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Noninvasive Prenatal Diagnostics Players Market Share in 2021

3.2.2 Top 10 Noninvasive Prenatal Diagnostics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Noninvasive Prenatal Diagnostics Players Head Office, Products and Services Provided

3.4 Noninvasive Prenatal Diagnostics Mergers & Acquisitions

3.5 Noninvasive Prenatal Diagnostics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Noninvasive Prenatal Diagnostics Revenue and Market Share by Type (2017-2022)

4.2 Global Noninvasive Prenatal Diagnostics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Noninvasive Prenatal Diagnostics Revenue Market Share by Application (2017-2022)

5.2 Global Noninvasive Prenatal Diagnostics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Noninvasive Prenatal Diagnostics Revenue by Type (2017-2028)

6.2 North America Noninvasive Prenatal Diagnostics Revenue by Application (2017-2028)

6.3 North America Noninvasive Prenatal Diagnostics Market Size by Country

6.3.1 North America Noninvasive Prenatal Diagnostics Revenue by Country (2017-2028)

6.3.2 United States Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

6.3.3 Canada Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

6.3.4 Mexico Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Noninvasive Prenatal Diagnostics Revenue by Type (2017-2028)

7.2 Europe Noninvasive Prenatal Diagnostics Revenue by Application (2017-2028)

7.3 Europe Noninvasive Prenatal Diagnostics Market Size by Country

7.3.1 Europe Noninvasive Prenatal Diagnostics Revenue by Country (2017-2028)

7.3.2 Germany Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

7.3.3 France Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

7.3.5 Russia Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

7.3.6 Italy Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Type (2017-2028)

8.2 Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Application (2017-2028)

8.3 Asia-Pacific Noninvasive Prenatal Diagnostics Market Size by Region

8.3.1 Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Region (2017-2028)

8.3.2 China Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

8.3.3 Japan Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

8.3.4 South Korea Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

8.3.5 India Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

8.3.7 Australia Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Noninvasive Prenatal Diagnostics Revenue by Type (2017-2028)

9.2 South America Noninvasive Prenatal Diagnostics Revenue by Application (2017-2028)

9.3 South America Noninvasive Prenatal Diagnostics Market Size by Country

9.3.1 South America Noninvasive Prenatal Diagnostics Revenue by Country (2017-2028)

9.3.2 Brazil Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

9.3.3 Argentina Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Type (2017-2028)

10.2 Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Application (2017-2028)

10.3 Middle East & Africa Noninvasive Prenatal Diagnostics Market Size by Country

10.3.1 Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Country (2017-2028)

10.3.2 Turkey Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

10.3.4 UAE Noninvasive Prenatal Diagnostics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Noninvasive Prenatal Diagnostics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Noninvasive Prenatal Diagnostics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Noninvasive Prenatal Diagnostics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Noninvasive Prenatal Diagnostics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Region (2023-2028)

Table 6. Natera Corporate Information, Head Office, and Major Competitors

Table 7. Natera Major Business

Table 8. Natera Noninvasive Prenatal Diagnostics Product and Solutions

Table 9. Natera Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Illumina Corporate Information, Head Office, and Major Competitors

Table 11. Illumina Major Business

Table 12. Illumina Noninvasive Prenatal Diagnostics Product and Solutions

Table 13. Illumina Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. BGI Diagnosis Corporate Information, Head Office, and Major Competitors

Table 15. BGI Diagnosis Major Business

Table 16. BGI Diagnosis Noninvasive Prenatal Diagnostics Product and Solutions

Table 17. BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Ariosa Diagnostics Corporate Information, Head Office, and Major Competitors

Table 19. Ariosa Diagnostics Major Business

Table 20. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions

Table 21. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 23. Quest Diagnostics Major Business

Table 24. Quest Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions

Table 25. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Premaitha Health Corporate Information, Head Office, and Major Competitors

Table 27. Premaitha Health Major Business

Table 28. Premaitha Health Noninvasive Prenatal Diagnostics Product and Solutions

Table 29. Premaitha Health Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. NIPD Genetics Corporate Information, Head Office, and Major Competitors

Table 31. NIPD Genetics Major Business

Table 32. NIPD Genetics Noninvasive Prenatal Diagnostics Product and Solutions

Table 33. NIPD Genetics Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Labcorp Corporate Information, Head Office, and Major Competitors

Table 35. Labcorp Major Business

Table 36. Labcorp Noninvasive Prenatal Diagnostics Product and Solutions

Table 37. Labcorp Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Ravgen Corporate Information, Head Office, and Major Competitors

Table 39. Ravgen Major Business

Table 40. Ravgen Noninvasive Prenatal Diagnostics Product and Solutions

Table 41. Ravgen Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. LifeCodexx Corporate Information, Head Office, and Major Competitors

Table 43. LifeCodexx Major Business

Table 44. LifeCodexx Noninvasive Prenatal Diagnostics Product and Solutions

Table 45. LifeCodexx Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. TrovaGene Corporate Information, Head Office, and Major Competitors

Table 47. TrovaGene Major Business

Table 48. TrovaGene Noninvasive Prenatal Diagnostics Product and Solutions

Table 49. TrovaGene Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 51. Quest Diagnostics Major Business

Table 52. Quest Diagnostics Noninvasive Prenatal Diagnostics Product and Solutions

Table 53. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Berry Genomics Corporate Information, Head Office, and Major Competitors

Table 55. Berry Genomics Major Business

Table 56. Berry Genomics Noninvasive Prenatal Diagnostics Product and Solutions

Table 57. Berry Genomics Noninvasive Prenatal Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Global Noninvasive Prenatal Diagnostics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 59. Global Noninvasive Prenatal Diagnostics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 60. Breakdown of Noninvasive Prenatal Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Noninvasive Prenatal Diagnostics Players Head Office, Products and Services Provided

Table 62. Noninvasive Prenatal Diagnostics Mergers & Acquisitions in the Past Five Years

Table 63. Noninvasive Prenatal Diagnostics New Entrants and Expansion Plans

Table 64. Global Noninvasive Prenatal Diagnostics Revenue (USD Million) by Type (2017-2022)

Table 65. Global Noninvasive Prenatal Diagnostics Revenue Share by Type (2017-2022)

Table 66. Global Noninvasive Prenatal Diagnostics Revenue Forecast by Type (2023-2028)

Table 67. Global Noninvasive Prenatal Diagnostics Revenue by Application (2017-2022)

Table 68. Global Noninvasive Prenatal Diagnostics Revenue Forecast by Application (2023-2028)

Table 69. North America Noninvasive Prenatal Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 70. North America Noninvasive Prenatal Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 71. North America Noninvasive Prenatal Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 72. North America Noninvasive Prenatal Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 73. North America Noninvasive Prenatal Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 74. North America Noninvasive Prenatal Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 75. Europe Noninvasive Prenatal Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 76. Europe Noninvasive Prenatal Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 77. Europe Noninvasive Prenatal Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 78. Europe Noninvasive Prenatal Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 79. Europe Noninvasive Prenatal Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 80. Europe Noninvasive Prenatal Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 81. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 82. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 83. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 84. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 85. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Region (2017-2022) & (USD Million)

Table 86. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue by Region (2023-2028) & (USD Million)

Table 87. South America Noninvasive Prenatal Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 88. South America Noninvasive Prenatal Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 89. South America Noninvasive Prenatal Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 90. South America Noninvasive Prenatal Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 91. South America Noninvasive Prenatal Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 92. South America Noninvasive Prenatal Diagnostics Revenue by Country (2023-2028) & (USD Million)

Table 93. Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Type (2017-2022) & (USD Million)

Table 94. Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Type (2023-2028) & (USD Million)

Table 95. Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Application (2017-2022) & (USD Million)

Table 96. Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Application (2023-2028) & (USD Million)

Table 97. Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Country (2017-2022) & (USD Million)

Table 98. Middle East & Africa Noninvasive Prenatal Diagnostics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Noninvasive Prenatal Diagnostics Picture

Figure 2. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Type in 2021

Figure 3. Services

Figure 4. Instrument

Figure 5. Noninvasive Prenatal Diagnostics Revenue Market Share by Application in 2021

Figure 6. Hospital Picture

Figure 7. Personal Picture

Figure 8. Other Picture

Figure 9. Global Noninvasive Prenatal Diagnostics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Noninvasive Prenatal Diagnostics Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Region (2017-2028)

Figure 12. Global Noninvasive Prenatal Diagnostics Revenue Market Share by Region in 2021

Figure 13. North America Noninvasive Prenatal Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Noninvasive Prenatal Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Noninvasive Prenatal Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Noninvasive Prenatal Diagnostics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Noninvasive Prenatal Diagnostics Market Drivers

Figure 19. Noninvasive Prenatal Diagnostics Market Restraints

Figure 20. Noninvasive Prenatal Diagnostics Market Trends

Figure 21. Natera Recent Developments and Future Plans

Figure 22. Illumina Recent Developments and Future Plans

Figure 23. BGI Diagnosis Recent Developments and Future Plans

Figure 24. Ariosa Diagnostics Recent Developments and Future Plans

Figure 25. Quest Diagnostics Recent Developments and Future Plans

Figure 26. Premaitha Health Recent Developments and Future Plans

Figure 27. NIPD Genetics Recent Developments and Future Plans

Figure 28. Labcorp Recent Developments and Future Plans

Figure 29. Ravgen Recent Developments and Future Plans

Figure 30. LifeCodexx Recent Developments and Future Plans

Figure 31. TrovaGene Recent Developments and Future Plans

Figure 32. Quest Diagnostics Recent Developments and Future Plans

Figure 33. Berry Genomics Recent Developments and Future Plans

Figure 34. Global Noninvasive Prenatal Diagnostics Revenue Share by Players in 2021

Figure 35. Noninvasive Prenatal Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Noninvasive Prenatal Diagnostics Revenue Market Share in 2021

Figure 37. Global Top 10 Players Noninvasive Prenatal Diagnostics Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Noninvasive Prenatal Diagnostics Revenue Share by Type in 2021

Figure 40. Global Noninvasive Prenatal Diagnostics Market Share Forecast by Type (2023-2028)

Figure 41. Global Noninvasive Prenatal Diagnostics Revenue Share by Application in 2021

Figure 42. Global Noninvasive Prenatal Diagnostics Market Share Forecast by Application (2023-2028)

Figure 43. North America Noninvasive Prenatal Diagnostics Sales Market Share by Type (2017-2028)

Figure 44. North America Noninvasive Prenatal Diagnostics Sales Market Share by Application (2017-2028)

Figure 45. North America Noninvasive Prenatal Diagnostics Revenue Market Share by Country (2017-2028)

Figure 46. United States Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Noninvasive Prenatal Diagnostics Sales Market Share by Type (2017-2028)

Figure 50. Europe Noninvasive Prenatal Diagnostics Sales Market Share by Application (2017-2028)

Figure 51. Europe Noninvasive Prenatal Diagnostics Revenue Market Share by Country (2017-2028)

Figure 52. Germany Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Noninvasive Prenatal Diagnostics Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Noninvasive Prenatal Diagnostics Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Noninvasive Prenatal Diagnostics Revenue Market Share by Region (2017-2028)

Figure 60. China Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Noninvasive Prenatal Diagnostics Sales Market Share by Type (2017-2028)

Figure 67. South America Noninvasive Prenatal Diagnostics Sales Market Share by Application (2017-2028)

Figure 68. South America Noninvasive Prenatal Diagnostics Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Noninvasive Prenatal Diagnostics Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Noninvasive Prenatal Diagnostics Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Noninvasive Prenatal Diagnostics Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Noninvasive Prenatal Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz